This insulin-pump company’s stock is plunging, and executives say it’s because diabetics in U.S. can’t afford the technology
Tandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday,…
Read MoreTandem Diabetes Care Inc. shares plummeted more than 20% after the company reported earnings Wednesday,…
Read MoreEli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read MoreA pair of new drugs offer something many Americans desperately want: a way to lose…
Read More